Advantages of multiple clinical tests for determining the optimum treatment strategy for ER-positive breast cancer

Nat Clin Pract Oncol. 2008 Jul;5(7):376-7. doi: 10.1038/ncponc1139. Epub 2008 May 27.
No abstract available

MeSH terms

  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / metabolism
  • Combined Modality Therapy
  • Female
  • Gene Expression Profiling
  • Genetic Markers
  • Humans
  • Neoplasm Recurrence, Local
  • Predictive Value of Tests
  • Prognosis
  • Receptors, Estrogen / drug effects
  • Receptors, Estrogen / genetics*
  • Selective Estrogen Receptor Modulators / pharmacology*
  • Selective Estrogen Receptor Modulators / therapeutic use
  • Tamoxifen / pharmacology*
  • Tamoxifen / therapeutic use
  • Treatment Outcome

Substances

  • Genetic Markers
  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators
  • Tamoxifen